Collagen News

The theory: By stimulating specific pressure points you can increase cell turnover, stimulate collagen production and improve circulation. The lowdown: Cosmetic surgery may be the gold standard for anti-aging among Western medicine practitioners.

More: continued here

Rivalries, friendly or no, always make things more exciting. SHANNON TEOH has the post-mortem on Kanye West’s overwhelming victory over 50 Cent last month.

More: continued here

Orthovita Inc. intends to acquire material, equipment and a technology license from Allergan Inc. for the continuing production of Orthovita’s Vitagel surgical blood-clotting product.

More: continued here

Innocoll Technologies, a subsidiary of Innocoll, has filed an investigational new drug application for its CollaRx bupivacaine topical, which is under development for the treatment of painful chronic skin ulcers and burns.

More: continued here

10/19/2007 - Biocell Technology has introduced a version of its Biocell collagen II ingredient that is being marketed as taste-free and therefore with applications expanded to include ready-to-drink formulations, chewables and functional foods.

More: continued here

LifeNet Health has entered into a supply agreement with Osteotech to provide tissue that will be utilized by Osteotech for its core DBM, Biocomposite and Collagen technologies.

More: continued here

MALVERN, Pa.—-Orthovita, Inc. , a spine and orthopedic biosurgery company, announced today that it has entered into a binding term sheet to acquire raw material, equipment and a technology license from Allergan, Inc. and its affiliate Allergan Sales, LLC for an aggregate purchase price of approximately $6.6 million in cash.

More: continued here

Cystic fibrosis (CF) is an inherited disease caused by mutations in the CFTR gene. Each mutation has number of effects on the cells of the lungs.

More: continued here

Osteoporosis prevention and treatment has long focused mainly on women. It is true that men build larger and stronger bones early in life and are less likely to develop this disease, which is characterized by less dense, brittle bone mass more susceptible to fracture.

More: continued here

Osteotech, Inc. announced today that it has entered into a tissue supply agreement with LifeNet Health, Inc. Pursuant to the agreement, LifeNet Health will provide Osteotech with tissue which will be utilized by Osteotech for its core DBM, Biocomposite and Collagen Technologies.

More: continued here